These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15017601)

  • 21. Early virological response in 1220 patients with HCV (genotype lb) chronic hepatitis and cirrhosis treated with PegInterferon plus Ribavirin.
    Pascu O; Voiculescu M; Gheorghe L; Micu L; Seicean A; Iliescu L; Mocan T; Ceauşu E; Mateescu B
    Rom J Intern Med; 2011; 49(2):105-12. PubMed ID: 22303601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis.
    Syed E; Rahbin N; Weiland O; Carlsson T; Oksanen A; Birk M; Davidsdottir L; Hagen K; Hultcrantz R; Aleman S
    Scand J Gastroenterol; 2008; 43(11):1378-86. PubMed ID: 18615358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of hepatitis C treatment may be enhanced by a longer interferon administration.
    Strauss E; Sette Júnior H
    Liver Int; 2003 Dec; 23(6):410-2. PubMed ID: 14986814
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.
    Anatol P; Robert F; Danuta P
    World J Gastroenterol; 2005 Mar; 11(12):1854-8. PubMed ID: 15793880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.
    Harrison SA; Hamzeh FM; Han J; Pandya PK; Sheikh MY; Vierling JM
    Hepatology; 2012 Aug; 56(2):464-73. PubMed ID: 22334369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract]   [Full Text] [Related]  

  • 27. Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
    Younossi ZM; McCullough AC; Barnes DS; Post A; Ong JP; O'Shea R; Martin LM; Bringman D; Farmer D; Levinthal G; Mullen KD; Carey WD; Tavill AS; Ferguson R; Gramlich T
    Dig Dis Sci; 2005 May; 50(5):970-5. PubMed ID: 15906777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characterization and peculiarities of the clinical course of low-activity hepatitis C].
    Karpov SIu; Krel' PE
    Klin Med (Mosk); 2005; 83(1):14-9. PubMed ID: 15759484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C. Saving the liver].
    Paul A
    MMW Fortschr Med; 1999 Nov; 141(46):16. PubMed ID: 10795138
    [No Abstract]   [Full Text] [Related]  

  • 30. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting].
    Saiz de la Hoya-Zamácola P; Marco-Mouriño A; Clemente-Ricote G; Portilla-Sogorb J; Boix-Martínez V; Núñez-Martínez O; Reus-Bañuls S; Teixidó i Pérez N
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):568-75. PubMed ID: 17125677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.
    Schalm SW; Weiland O; Hansen BE; Milella M; Lai MY; Hollander A; Michielsen PP; Bellobuono A; Chemello L; Pastore G; Chen DS; Brouwer JT
    Gastroenterology; 1999 Aug; 117(2):408-13. PubMed ID: 10419923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of patients with chronic hepatitis C who never had been treated].
    Hézode C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B38-49. PubMed ID: 12180307
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.
    Jung CH; Um SH; Kim TH; Yim SY; Suh SJ; Yim HJ; Seo YS; Choi HS; Chun HJ
    Gut Liver; 2016 Sep; 10(5):808-17. PubMed ID: 27114417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peginterferon alpha and ribavirin therapy for difficult-to-treat chronic hepatitis C patients].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2002; 56 Suppl 4():51-4. PubMed ID: 14750261
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hepatitis C virus-related cirrhosis].
    Bronowicki JP
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
    [No Abstract]   [Full Text] [Related]  

  • 36. Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
    de Lédinghen V; Trimoulet P; Winnock M; Bernard PH; Bourlière M; Portal I; Rémy AJ; Szostak N; Lévy S; Tran A; Abergel A; Chêne G; Fleury H; Couzigou P;
    J Hepatol; 2002 Jun; 36(6):819-26. PubMed ID: 12044534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.
    Di Marco V; Calvaruso V; Grimaudo S; Ferraro D; Pipitone RM; Di Stefano R; Craxì A
    J Viral Hepat; 2013 Feb; 20(2):113-21. PubMed ID: 23301546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
    Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
    BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
    [No Abstract]   [Full Text] [Related]  

  • 40. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
    Shiffman ML; Di Bisceglie AM; Lindsay KL; Morishima C; Wright EC; Everson GT; Lok AS; Morgan TR; Bonkovsky HL; Lee WM; Dienstag JL; Ghany MG; Goodman ZD; Everhart JE;
    Gastroenterology; 2004 Apr; 126(4):1015-23; discussion 947. PubMed ID: 15057741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.